Together, we are stronger.
Chemotherapy for parathyroid cancer
Chemotherapy is rarely used to treat parathyroid cancer. Because parathyroid cancer is rare, there are very few clinical trials that have shown that any particular drug can successfully treat this disease.
Chemotherapy is the use of anti-cancer (cytotoxic) drugs to treat cancer. It is usually a systemic therapysystemic therapyTreatment that travels through the bloodstream to reach cells all over the body. that circulates throughout the body and destroys cancer cells, including those that may have broken away from the primary tumour.
Chemotherapy may be used:
- to treat parathyroid cancer that cannot be completely removed by surgery
- for recurrent and metastatic disease
Drugs, doses and schedules vary from person to person.
The chemotherapy drug that has been used to treat parathyroid cancer is:
- dacarbazine (DTIC)
Chemotherapy drugs that have been used in combination to treat parathyroid cancer are:
- 5-fluorouracil (Adrucil, 5-FU), cyclophosphamide (Cytoxan, Procytox) and paclitaxel (Taxol)
- 5-fluorouracil, cyclophosphamide and dacarbazine
For more detailed information on specific drugs, go to sources of drug information.
Establishing a national caregivers strategy
The Canadian Cancer Society is actively lobbying the federal government to establish a national caregivers strategy to ensure there is more financial support for this important group of people.